Transitional Drugs 6
- Published
- Published 26 November 2025
- Deadline
- Closed 8 January 2026
Overview
Key details
- Country
- United Kingdom
- Status
- In delivery
- Category
- Goods
- Estimated value
- £12,307,059
- Procedure
- Open
- SME suitable
- Yes
- Published
- 26 November 2025
- Questions by
- 7 January 2026
- Deadline
- Closed
Award outcome
- Awarded value
- £1,637,728
- Award date
- 29 January 2026
- Contract period
- 1 March 2026 → 29 February 2028
- Accord UK Ltd
- Amgen Ltd
- Celltrion Healthcare
- Dr Reddy's Laboratories (UK) Ltd
- Fresenius Kabi Ltd
- Gedeon Richter UK Ltd
- Organon Pharmaceuticals Ltd
- Samsung Bioepsis UK Ltd
- Sandoz Ltd
- Teva UK Ltd
- Thornton & Ross Ltd
- Zentiva Pharma UK Ltd
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract
30 March 2026
View notice ↗Contract
4 February 2026
View notice ↗Contract Notice
27 November 2025
View notice ↗Prior Information Notice
26 November 2025
View notice ↗
Contracting authority
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
BuyerCardiff, United Kingdom
GB-NHS: RQF
Authority website ↗NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
BuyerCardiff, United Kingdom
GB-PPON: PXWV-6492-CGMN
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.